ATE555114T1 - Verfahren zur herstellung von mirtazapin - Google Patents
Verfahren zur herstellung von mirtazapinInfo
- Publication number
- ATE555114T1 ATE555114T1 AT08722032T AT08722032T ATE555114T1 AT E555114 T1 ATE555114 T1 AT E555114T1 AT 08722032 T AT08722032 T AT 08722032T AT 08722032 T AT08722032 T AT 08722032T AT E555114 T1 ATE555114 T1 AT E555114T1
- Authority
- AT
- Austria
- Prior art keywords
- mirtazapine
- phenylpiperazin
- cyclization
- propanol
- pyridine
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 6
- 229960001785 mirtazapine Drugs 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- PYZPABZGIRHQTA-UHFFFAOYSA-N [2-(4-methyl-2-phenylpiperazin-1-yl)pyridin-3-yl]methanol Chemical compound C1N(C)CCN(C=2C(=CC=CN=2)CO)C1C1=CC=CC=C1 PYZPABZGIRHQTA-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 2
- 239000011541 reaction mixture Substances 0.000 abstract 2
- 238000007363 ring formation reaction Methods 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007075573A JP5192707B2 (ja) | 2007-03-22 | 2007-03-22 | ミルタザピンの製造方法 |
| PCT/JP2008/054628 WO2008114691A1 (ja) | 2007-03-22 | 2008-03-13 | ミルタザピンの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555114T1 true ATE555114T1 (de) | 2012-05-15 |
Family
ID=39765800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08722032T ATE555114T1 (de) | 2007-03-22 | 2008-03-13 | Verfahren zur herstellung von mirtazapin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8173804B2 (de) |
| EP (1) | EP2135870B1 (de) |
| JP (1) | JP5192707B2 (de) |
| KR (1) | KR101418620B1 (de) |
| CN (1) | CN101541798B (de) |
| AT (1) | ATE555114T1 (de) |
| AU (1) | AU2008227637B2 (de) |
| BR (1) | BRPI0805835A2 (de) |
| CA (1) | CA2664286A1 (de) |
| DK (1) | DK2135870T3 (de) |
| ES (1) | ES2386165T3 (de) |
| IL (1) | IL197572A (de) |
| PL (1) | PL2135870T3 (de) |
| PT (1) | PT2135870E (de) |
| WO (1) | WO2008114691A1 (de) |
| ZA (1) | ZA200901559B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6876003B2 (ja) | 2015-02-27 | 2021-05-26 | デクラ リミテッド | イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置 |
| JP6452575B2 (ja) * | 2015-08-19 | 2019-01-16 | 株式会社トクヤマ | ミルタザピンの製造方法 |
| JP2017088564A (ja) * | 2015-11-13 | 2017-05-25 | 株式会社トクヤマ | ミルタザピンの製造方法 |
| JP6571497B2 (ja) * | 2015-11-13 | 2019-09-04 | 株式会社トクヤマ | ミルタザピンの製造方法 |
| JP7018840B2 (ja) * | 2018-07-04 | 2022-02-14 | 住友化学株式会社 | フェニルピペラジンピリジンメチルアセテートの製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| TR200103028T2 (tr) | 1999-04-19 | 2002-01-21 | Teva Pharmaceutical Industries Ltd. | Piperazin halka içeren bileşiklerin yeni sentezi ve kristalleştirilmesi |
| US6545149B2 (en) | 1999-04-19 | 2003-04-08 | Teva Pharmaceutical Industries Ltd. | Synthesis and crystallization of piperazine ring-containing compounds |
| AU6019900A (en) * | 1999-11-24 | 2001-06-04 | Sumika Fine Chemicals Co., Ltd. | Anhydrous mirtazapine crystals and process for producing the same |
| US6660730B2 (en) | 2000-11-27 | 2003-12-09 | Sumika Fine Chemicals Co., Ltd. | Anhydrous mirtazapine and process for preparing the same |
| US6434049B1 (en) * | 2000-12-29 | 2002-08-13 | Intel Corporation | Sample and hold voltage reference source |
| UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
-
2007
- 2007-03-22 JP JP2007075573A patent/JP5192707B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-13 KR KR1020097006525A patent/KR101418620B1/ko not_active Expired - Fee Related
- 2008-03-13 US US12/443,662 patent/US8173804B2/en not_active Expired - Fee Related
- 2008-03-13 PT PT08722032T patent/PT2135870E/pt unknown
- 2008-03-13 EP EP08722032A patent/EP2135870B1/de not_active Not-in-force
- 2008-03-13 CA CA002664286A patent/CA2664286A1/en not_active Abandoned
- 2008-03-13 CN CN2008800007408A patent/CN101541798B/zh not_active Expired - Fee Related
- 2008-03-13 WO PCT/JP2008/054628 patent/WO2008114691A1/ja not_active Ceased
- 2008-03-13 AU AU2008227637A patent/AU2008227637B2/en not_active Ceased
- 2008-03-13 ES ES08722032T patent/ES2386165T3/es active Active
- 2008-03-13 PL PL08722032T patent/PL2135870T3/pl unknown
- 2008-03-13 DK DK08722032.3T patent/DK2135870T3/da active
- 2008-03-13 AT AT08722032T patent/ATE555114T1/de active
- 2008-03-13 BR BRPI0805835-0A patent/BRPI0805835A2/pt not_active IP Right Cessation
-
2009
- 2009-03-04 ZA ZA2009/01559A patent/ZA200901559B/en unknown
- 2009-03-12 IL IL197572A patent/IL197572A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5192707B2 (ja) | 2013-05-08 |
| EP2135870B1 (de) | 2012-04-25 |
| IL197572A0 (en) | 2009-12-24 |
| ES2386165T3 (es) | 2012-08-10 |
| US20100029934A1 (en) | 2010-02-04 |
| JP2008231062A (ja) | 2008-10-02 |
| KR20090121270A (ko) | 2009-11-25 |
| CN101541798B (zh) | 2011-09-14 |
| US8173804B2 (en) | 2012-05-08 |
| CA2664286A1 (en) | 2008-09-25 |
| CN101541798A (zh) | 2009-09-23 |
| WO2008114691A1 (ja) | 2008-09-25 |
| ZA200901559B (en) | 2010-02-24 |
| AU2008227637A1 (en) | 2008-09-25 |
| EP2135870A1 (de) | 2009-12-23 |
| PL2135870T3 (pl) | 2012-07-31 |
| KR101418620B1 (ko) | 2014-07-14 |
| PT2135870E (pt) | 2012-05-11 |
| EP2135870A4 (de) | 2011-06-08 |
| DK2135870T3 (da) | 2012-07-16 |
| IL197572A (en) | 2013-03-24 |
| AU2008227637B2 (en) | 2012-02-16 |
| BRPI0805835A2 (pt) | 2011-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20210064B1 (ar) | طريقة لانتاج ( z)-ألفا-فلورو-بيتا-أمينو-أكريل الدهيدات مستبدلة | |
| EP2415709A4 (de) | Verfahren zur herstellung von bis(fluorsulfonyl-)imidsalz, verfahren zur herstellung von fluorsulfat und verfahren zur herstellung von bis(fluorsulfonyl-)onsalz | |
| ATE446941T1 (de) | Verfahren zur gekoppelten herstellung von chlor und isocyanaten | |
| IN2012DN03176A (de) | ||
| EP2123636A4 (de) | Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats | |
| DE602007003024D1 (de) | Neues verfahren zur salzherstellung | |
| ATE487702T1 (de) | Verfahren zum herstellen von 3-dihalomethyl- pyrazol-4-carbonsäurederivaten | |
| DE602005023268D1 (de) | Verfahren zur herstellung von acrylsäure | |
| EP2135870A4 (de) | Verfahren zur herstellung von mirtazapin | |
| EP2592064A4 (de) | Verfahren zur herstellung eines gereinigten chlorogensäurehaltigen pharmazeutischen präparats | |
| EA201001395A1 (ru) | Специфичные примеси монтелукаста | |
| NZ751256A (en) | Method for producing the crystalline form of modification a of calcobutrol | |
| ATE550296T1 (de) | Verfahren zur herstellung von hochreiner phosphorsäure | |
| EP2660246A4 (de) | Verbindung, nukleinsäure, verfahren zur herstellung der nukleinsäure und kit zur herstellung der nukleinsäure | |
| DE602007007743D1 (de) | Verfahren zur herstellung eines organischen hydroperoxids, industrielle einrichtung dafür und verfahren mittels verwendung eines derartigen hydroperoxids zur herstellung eines alkylenoxids | |
| EA200971019A1 (ru) | Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты | |
| RU2010142809A (ru) | Способ получения синтетического диоксида кремния высокой чистоты | |
| CY1114331T1 (el) | Μεθοδος για την παρασκευη αμιδιων καρβοξυλικου οξεος χρησιμων στη θεραπευτικη αγωγη μυϊκων παθησεων | |
| AR090916A1 (es) | Metodo para la fabricacion de naltrexona | |
| ATE423096T1 (de) | Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| GEP20156350B (en) | New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid | |
| ATE466010T1 (de) | Verfahren zur herstellung von candesartan | |
| ATE543820T1 (de) | Verfahren zur herstellung von 2,3,4,9-tetrahydro- 1h-beta-carbolin-3-carbonsäureestern | |
| MX2012013388A (es) | Metodo para fabricar 1-alquil-3-difluorometil-5-hidroxipirazoles. | |
| MX2019006209A (es) | Proceso para la preparacion de carmin de indigo. |